| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Antonio Macrì | |
| Edoardo Saladino | |||
| Anna Fortugno | |||
| P2860 | cites work | Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G | Q33335882 |
| Peritoneal carcinomatosis: feature of dissemination. A review. | Q33608172 | ||
| Management of peritoneal-surface malignancy: the surgeon's role | Q33827705 | ||
| Pseudomyxoma peritonei | Q34391046 | ||
| Experience with peritoneal mesothelioma at the Milan National Cancer Institute. | Q34391082 | ||
| Peritoneal carcinomatosis of colorectal origin. | Q34391090 | ||
| Peritoneal carcinosis of ovarian origin. | Q34391112 | ||
| Management of peritoneal surface component of ovarian cancer | Q35563237 | ||
| Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options | Q35651938 | ||
| Carcinomatosis from gastrointestinal cancer | Q35682209 | ||
| The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy | Q37252056 | ||
| Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options | Q37528436 | ||
| Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. | Q37812968 | ||
| Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. | Q41911448 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. | Q43765205 | ||
| Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution | Q43910359 | ||
| Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion | Q45288550 | ||
| The treatment of peritoneal carcinomatosis in elderly patients. | Q46783635 | ||
| Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculature. | Q50515653 | ||
| Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. | Q53286355 | ||
| Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. | Q53959071 | ||
| An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma | Q64046604 | ||
| Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives | Q66921979 | ||
| Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy | Q67919758 | ||
| Effects of surgery on the cell kinetics of residual tumor | Q68269709 | ||
| Ultrastructural changes induced by hyperthermia in Chinese hamster V79 fibroblasts | Q69614035 | ||
| Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique | Q73327596 | ||
| Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer | Q75244449 | ||
| Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding | Q76390946 | ||
| Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis | Q78865706 | ||
| Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures | Q79121171 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Peritonectomy procedures | Q79182991 | ||
| Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis | Q79345552 | ||
| Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome | Q83653841 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 169-174 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | World journal of gastrointestinal oncology | Q27723329 |
| P1476 | title | Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia | |
| P478 | volume | 3 |
| Q40664317 | Evaluation of cisplatin plasma levels in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q37594150 | Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. |
| Q86194215 | Intraperitoneal hyperthermic chemotherapy: which drugs? |
| Q52593051 | Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: Report of two cases. |
| Q27313250 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. |
| Q36909380 | Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC) |
| Q38131754 | The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse. |
| Q41603309 | Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy |
Search more.